Life Science Companies are Litigation Targets for Unhappy Investors Post author:Sam Post published:February 22, 2018 Post category:BioPharma Life science companies are popular targets for securities fraud litigation. Source: BioSpace You Might Also Like How Biogen Lost Its Chance to Be the Hunter and Became the Hunted in Just a Few Months April 16, 2017 BioMarin To Host Second Quarter 2017 Financial Results Conference Call And Webcast On Wednesday, August 2 At 4:30pm ET July 18, 2017 Why This Pharma May be the Best CAR-T Bet, Not Gilead October 19, 2017
How Biogen Lost Its Chance to Be the Hunter and Became the Hunted in Just a Few Months April 16, 2017
BioMarin To Host Second Quarter 2017 Financial Results Conference Call And Webcast On Wednesday, August 2 At 4:30pm ET July 18, 2017
